Solutions
Drug Development
Pulmonary Interventions
Therapeutic Areas
COPD
Bronchiectasis Disease
Severe Asthma
Cystic Fibrosis
Technology
Evidence & Expertise
Publications
Research Projects
Advisory Board
Company
About Us
Events
Quality & Compliance
News
Career
Contact
Solutions
Drug Development
Pulmonary Interventions
Therapeutic Areas
COPD
Bronchiectasis Disease
Severe Asthma
Cystic Fibrosis
Technology
Evidence & Expertise
Publications
Research Projects
Advisory Board
Company
About Us
Events
Quality & Compliance
News
Career
Contact
Let's talk
Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study
Source:
Respiratory Research
Publication link
